2024 Annual Venture Report | Illinois Life Sciences Investment Reaches Record $1.24B
To celebrate the funding and milestone achievements of life science companies across Illinois and elevate the outstanding stories of life-saving innovation in our community, iBIO has produced our inaugural Annual Venture Report. Illinois’ life sciences ecosystem achieved unprecedented growth with $1.24 billion in venture investments across 99 companies, marking the state’s emergence as a premier biotechnology hub. This comprehensive report showcases the remarkable achievements of Illinois-based life sciences companies, from groundbreaking AI-driven drug discovery platforms to innovative treatments for neurodegenerative diseases. With employment in the sector growing 20 times faster than the state’s overall economy and major infrastructure investments transforming Chicago into a top-10 biopharma destination, Illinois is positioned at the forefront of healthcare innovation.
- $1.24B Total Investment
- 99 Companies Funded
- 93,402 Life Sciences Jobs
- 20x Growth Rate vs. State Average
- Comprehensive analysis of 99 Illinois life sciences companies and their funding rounds
- Featured success stories including Vanqua Bio’s $45M Series B and Cour Pharmaceuticals’ $105M Series A
- Investment trends showing AI/Software Solutions dominating with 44% of total funding
- Infrastructure developments including 2M+ square feet of new lab space
- Strategic insights into Illinois’ emergence as a top-10 biopharma hub
